XBiotech (XBIT) Other Non Operating Income (2014 - 2026)

XBiotech's Other Non Operating Income history runs 12 years deep, the most recent figure standing at $1.1 million for Q4 2025.

• In Q4 2025, Other Non Operating Income rose 170.27% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.3 million (up 200.0% YoY), while the FY2025 annual figure was $3.3 million, up 663.89% from the prior year.
• Other Non Operating Income for Q4 2025 stood at $1.1 million, up from -$85000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $3.1 million in Q4 2022, with the low at -$1.3 million in Q3 2021.
• The 5-year median for Other Non Operating Income is $77500.0 (2023), against an average of $250250.0.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income slumped 5850.0% in 2022, then surged 730.25% in 2023.
• XBiotech's Other Non Operating Income stood at -$579000.0 in 2021, then surged by 629.71% to $3.1 million in 2022, then plunged by 66.97% to $1.0 million in 2023, then slumped by 59.82% to $407000.0 in 2024, then jumped by 170.27% to $1.1 million in 2025.
• Business Quant data shows XBIT's Other Non Operating Income at $1.1 million in Q4 2025, -$85000.0 in Q3 2025, and -$3000.0 in Q2 2025.